Healthcare -
Biotechnology - NASDAQ - US
$ 175.65
-2.01 %
$ 5.06 B
Market Cap
58.55
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Krystal Biotech, Inc.
| Revenue | 291 M |
| Cost Of Revenue | 20.1 M |
| Gross Profit | 270 M |
| Operating Expenses | 205 M |
| Operating Income | 65.7 M |
| Other Expenses | -23.5 M |
| Net Income | 89.2 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 290.5 | 50.7 | 0 | 0 | 0 | 0 | 1.0 | 0 | 0 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 20.1 | 3.1 | 4.1 | 2.8 | 1.9 | 1.0 | 0.1 | 23 K | 2 K |
| Gross Profit | 270.5 | 47.6 | (4.1) | (2.8) | (1.9) | (1.0) | 0.9 | 23 K | 2 K |
| OPERATING INCOME | |||||||||
| Operating Expenses | 204.8 | 157.3 | 120.2 | 68.3 | 33.0 | 22.1 | 11.9 | 4.8 | 1.1 |
| Selling, General and Administrative Expenses | 113.7 | 98.4 | 77.7 | 40.4 | 15.1 | 6.5 | 4.2 | 1.6 | 0.4 |
| Research and Development Expenses | 53.6 | 46.4 | 42.5 | 27.9 | 17.9 | 15.6 | 7.8 | 3.2 | 0.7 |
| Operating Income | 65.7 | (109.7) | (145.2) | (68.3) | (33.0) | (22.1) | (11.9) | (4.8) | (1.1) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 0 | 0 | 5.2 | 1.5 | 0 | 0 | 1.0 | 3.1 | 7 K |
| Total Other Income | 29.7 | 122.6 | 5.2 | (1.3) | 0.8 | 3.0 | 1.0 | (3.1) | 7 K |
| Pre-Tax Income | 95.4 | 12.9 | (140.0) | (69.6) | (32.2) | (19.1) | (10.9) | (7.9) | (1.1) |
| NET INCOME | |||||||||
| Tax Provision | 6.2 | 2.0 | 34.0 | 2.7 | 1.6 | 0.6 | 20.1 K | 0 | 0 |
| Net Income | 89.2 | 10.9 | (140.0) | (69.6) | (32.2) | (19.1) | (10.9) | (7.9) | (1.1) |
| EPS | 3.12 | 0.4 | 5.49 | 3.13 | 1.71 | 1.2 | 0.97 | 1.48 | 0.27 |